Aart-Jan van der Lely
Overview
Explore the profile of Aart-Jan van der Lely including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
921
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bolier M, de Winter D, Fiocco M, van den Berg S, Bresters D, van Dulmen-den Broeder E, et al.
J Clin Endocrinol Metab
. 2025 Feb;
PMID: 39916355
Context/objective: Diabetes mellitus (DM), a possible adverse effect of childhood cancer treatment, is strongly associated with cardiovascular disease and early mortality in adult childhood cancer survivors (CCS). Here, we assess...
2.
Bolier M, de Winter D, Pluimakers V, Fiocco M, van den Berg S, Bresters D, et al.
Cancer
. 2025 Jan;
131(1):e35681.
PMID: 39748458
Background: Because the occurrence of metabolic syndrome (MetS) might contribute to childhood cancer survivor's excess risk of cardiovascular disease, the authors assessed the prevalence and determinants of MetS in the...
3.
Bolier M, Pluimakers V, de Winter D, Fiocco M, van den Berg S, Bresters D, et al.
Eur J Endocrinol
. 2024 Nov;
191(6):588-603.
PMID: 39564675
Objective: Childhood cancer survivors (CCS) face an increased risk of early cardiovascular disease (CVD). In our nationwide CCS cohort, we assessed the prevalence and determinants of dyslipidemia, a well-established risk...
4.
Neggers S, Berk K, van der Lely A
J Clin Endocrinol Metab
. 2023 Jan;
108(8):e642-e643.
PMID: 36695435
No abstract available.
5.
Verweij T, Slagboom T, van Varsseveld N, van der Lely A, Drent M, van Bunderen C
Eur J Endocrinol
. 2021 Oct;
185(6):793-801.
PMID: 34605771
Context: Cardiovascular (CV) risk profile might differ between growth hormone-treated patients with craniopharyngioma and non-functioning pituitary adenoma (NFPA), since patients with craniopharyngioma more frequently suffer from hypothalamic metabolic disruption. Objective:...
6.
Coopmans E, Schneiders J, El-Sayed N, Erler N, Hofland L, van der Lely A, et al.
Eur J Endocrinol
. 2020 May;
182(6):595-605.
PMID: 32375119
Objective: T2-signal intensity and somatostatin (SST) receptor expression are recognized predictors of therapy response in acromegaly. We investigated the relationship between these predictors and the hormonal and tumoral responses to...
7.
Coopmans E, El-Sayed N, Frystyk J, Magnusson N, Jorgensen J, van der Lely A, et al.
Endocrine
. 2020 Apr;
69(1):165-174.
PMID: 32333268
Purpose: Although quality of life (QoL) is improved in patients with acromegaly after disease control, QoL correlates only weakly with traditional biomarkers. Our objective is to investigate a potential relation...
8.
Coopmans E, Chunharojrith P, Neggers S, van der Ent M, Swagemakers S, Hollink I, et al.
Front Immunol
. 2019 Sep;
10:2079.
PMID: 31543881
Primary antibody deficiencies (PADs) and anterior pituitary dysfunction are both rare conditions. However, recent studies have remarkably reported the occurrence of anterior pituitary dysfunction in PAD patients. In this cross-sectional,...
9.
Coopmans E, van Meyel S, Pieterman K, van Ipenburg J, Hofland L, Donga E, et al.
Eur J Endocrinol
. 2019 Jun;
181(2):K21-K27.
PMID: 31167168
Prolactinomas are the most commonly encountered pituitary adenomas in the clinical setting. While most can be controlled by dopamine agonists, a subset of prolactinomas are dopamine-resistant and very aggressive. In...
10.
Buchfelder M, van der Lely A, Biller B, Webb S, Brue T, Strasburger C, et al.
Eur J Endocrinol
. 2018 Oct;
179(6):419-427.
PMID: 30325178
Objectives ACROSTUDY is an international, non-interventional study of acromegaly patients treated with pegvisomant (PEGV), a growth hormone receptor antagonist and has been conducted since 2004 in 15 countries to study...